Mats O Karlson (Mats O Karlsson, Mats Karlsson)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 56

Top Venues

CPT: pharmacometrics & systems pharmacology

Clinical pharmacology and therapeutics

Statistics in medicine

The AAPS journal

Uppsala Universitet

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Uppsala Universitet

Sweden

Professor :: Pharmaceutical Biosciences

Publications

Kinjal Sanghavi, Jakob Ribbing, James A Rogers, Mariam A Ahmed, Mats O Karlson, Nick H G Holford, Estelle Chasseloup, Malidi Ahamadi, Kenneth G Kowalski, Susan Cole, Essam Ghazaly, Janet R Wade, Chao Liu, Yaning Wang, Mirjam N Trame, Hao Zhu, Justin J Wilkins, null null
Covariate modeling in pharmacometrics: General points for consideration. CPT: pharmacometrics & systems pharmacology 13 (5) (2024)
Kinjal Sanghavi, Jakob Ribbing, James A Rogers, Mariam A Ahmed, Mats O Karlson, Nick H G Holford, Estelle Chasseloup, Malidi Ahamadi, Kenneth G Kowalski, Susan Cole, Essam Ghazaly, Janet R Wade, Chao Liu, Yaning Wang, Mirjam N Trame, Hao Zhu, Justin J Wilkins, null null
Covariate modeling in pharmacometrics: General points for consideration. CPT: pharmacometrics & systems pharmacology 13 (5) (2024)
Alzahra Hamdan, Andrew C Hooker, Xiaomei Chen, Andreas Traschütz, Rebecca Schüle, null null, null null, Matthis Synofzik, Mats O Karlson
Item performance of the scale for the assessment and rating of ataxia in rare and ultra-rare genetic ataxias. CPT: pharmacometrics & systems pharmacology (2024)
Alzahra Hamdan, Andrew C Hooker, Xiaomei Chen, Andreas Traschütz, Rebecca Schüle, null null, null null, Matthis Synofzik, Mats O Karlson
Item performance of the scale for the assessment and rating of ataxia in rare and ultra-rare genetic ataxias. CPT: pharmacometrics & systems pharmacology 13 (8) (2024)
Anders Thorsted, Chiara Zecchin, Alienor Berges, Mats O Karlson, Lena E Friberg
Predicting the Long-Term Effects of Therapeutic Neutralization of Oncostatin M on Human Hematopoiesis. Clinical pharmacology and therapeutics 116 (3) (2024)
Gustaf J Wellhagen, Ashraf Yassen, Dirk Garmann, Astrid Bröker, Alexander Solms, Yang Zhang, Maria C Kjellsson, Mats O Karlson
Evaluation of covariate effects in item response theory models. CPT: pharmacometrics & systems pharmacology 13 (5) (2024)
Leticia Arrington, Mats O Karlson
Comparison of Two Methods for Determining Item Characteristic Functions and Latent Variable Time-Course for Pharmacometric Item Response Models. The AAPS journal 26 (1) (2024)
Alzahra Hamdan, Andrew C Hooker, Xiaomei Chen, Andreas Traschütz, Rebecca Schüle, null null, null null, Matthis Synofzik, Mats O Karlson
Item performance of the scale for the assessment and rating of ataxia in rare and ultra-rare genetic ataxias. CPT: pharmacometrics & systems pharmacology 13 (8) (2024)
Gustaf J Wellhagen, Mats O Karlson, Maria C Kjellsson, Dirk Garmann, Astrid Bröker, Yang Zhang, Mika Nokela, Gerrit Weimann, Ashraf Yassen
Item response theory analysis of daytime sleepiness as a symptom of obstructive sleep apnea. CPT: pharmacometrics & systems pharmacology 13 (5) (2024)
Kinjal Sanghavi, Jakob Ribbing, James A Rogers, Mariam A Ahmed, Mats O Karlson, Nick H G Holford, Estelle Chasseloup, Malidi Ahamadi, Kenneth G Kowalski, Susan Cole, Essam Ghazaly, Janet R Wade, Chao Liu, Yaning Wang, Mirjam N Trame, Hao Zhu, Justin J Wilkins, null null
Covariate modeling in pharmacometrics: General points for consideration. CPT: pharmacometrics & systems pharmacology 13 (5) (2024)
Leticia Arrington, Mats O Karlson
Comparison of Two Methods for Determining Item Characteristic Functions and Latent Variable Time-Course for Pharmacometric Item Response Models. The AAPS journal 26 (1) (2024)
Gustaf J Wellhagen, Ashraf Yassen, Dirk Garmann, Astrid Bröker, Alexander Solms, Yang Zhang, Maria C Kjellsson, Mats O Karlson
Evaluation of covariate effects in item response theory models. CPT: pharmacometrics & systems pharmacology 13 (5) (2024)
Gustaf J Wellhagen, Ashraf Yassen, Dirk Garmann, Astrid Bröker, Alexander Solms, Yang Zhang, Maria C Kjellsson, Mats O Karlson
Evaluation of covariate effects in item response theory models. CPT: pharmacometrics & systems pharmacology (2024)
Mohamed Gewily, Elodie L Plan, Elham Yousefi, Franz König, Martin Posch, Franziska Hopfner, Günter U Höglinger, Mats O Karlson
Quantitative Comparisons of Progressive Supranuclear Palsy Rating Scale Versions Using Item Response Theory. Movement disorders : official journal of the Movement Disorder Society (2024)
Anders Thorsted, Chiara Zecchin, Alienor Berges, Mats O Karlson, Lena E Friberg
Predicting the Long-Term Effects of Therapeutic Neutralization of Oncostatin M on Human Hematopoiesis. Clinical pharmacology and therapeutics (2024)
Henrik B Nyberg, Xiaomei Chen, Mark Donnelly, Lanyan Fang, Liang Zhao, Mats O Karlson, Andrew C Hooker
Evaluation of model-integrated evidence approaches for pharmacokinetic bioequivalence studies using model averaging methods. CPT: pharmacometrics & systems pharmacology (2024)
Gustaf J Wellhagen, Ashraf Yassen, Dirk Garmann, Astrid Bröker, Alexander Solms, Yang Zhang, Maria C Kjellsson, Mats O Karlson
Evaluation of covariate effects in item response theory models. CPT: pharmacometrics & systems pharmacology 13 (5) (2024)
Gustaf J Wellhagen, Mats O Karlson, Maria C Kjellsson, Dirk Garmann, Astrid Bröker, Yang Zhang, Mika Nokela, Gerrit Weimann, Ashraf Yassen
Item response theory analysis of daytime sleepiness as a symptom of obstructive sleep apnea. CPT: pharmacometrics & systems pharmacology 13 (5) (2024)
Leticia Arrington, Mats O Karlson
Comparison of Two Methods for Determining Item Characteristic Functions and Latent Variable Time-Course for Pharmacometric Item Response Models. The AAPS journal 26 (1) (2024)
Kinjal Sanghavi, Jakob Ribbing, James A Rogers, Mariam A Ahmed, Mats O Karlson, Nick H G Holford, Estelle Chasseloup, Malidi Ahamadi, Kenneth G Kowalski, Susan Cole, Essam Ghazaly, Janet R Wade, Chao Liu, Yaning Wang, Mirjam N Trame, Hao Zhu, Justin J Wilkins, null null
Covariate modeling in pharmacometrics: General points for consideration. CPT: pharmacometrics & systems pharmacology 13 (5) (2024)
Gustaf J Wellhagen, Ashraf Yassen, Dirk Garmann, Astrid Bröker, Alexander Solms, Yang Zhang, Maria C Kjellsson, Mats O Karlson
Evaluation of covariate effects in item response theory models. CPT: pharmacometrics & systems pharmacology 13 (5) (2024)
Gustaf J Wellhagen, Mats O Karlson, Maria C Kjellsson, Dirk Garmann, Astrid Bröker, Yang Zhang, Mika Nokela, Gerrit Weimann, Ashraf Yassen
Item response theory analysis of daytime sleepiness as a symptom of obstructive sleep apnea. CPT: pharmacometrics & systems pharmacology 13 (5) (2024)
Xiaomei Chen, Rikard Nordgren, Stella Belin, Alzahra Hamdan, Shijun Wang, Tianwu Yang, Zhe Huang, Simon J Carter, Simon Buatois, João A Abrantes, Andrew C Hooker, Mats O Karlson
A fully automatic tool for development of population pharmacokinetic models. CPT: pharmacometrics & systems pharmacology (2024)
Kinjal Sanghavi, Jakob Ribbing, James A Rogers, Mariam A Ahmed, Mats O Karlson, Nick H G Holford, Estelle Chasseloup, Malidi Ahamadi, Kenneth G Kowalski, Susan Cole, Essam Ghazaly, Janet R Wade, Chao Liu, Yaning Wang, Mirjam N Trame, Hao Zhu, Justin J Wilkins, null null
Covariate modeling in pharmacometrics: General points for consideration. CPT: pharmacometrics & systems pharmacology (2024)
Gustaf J Wellhagen, Mats O Karlson, Maria C Kjellsson, Dirk Garmann, Astrid Bröker, Yang Zhang, Mika Nokela, Gerrit Weimann, Ashraf Yassen
Item response theory analysis of daytime sleepiness as a symptom of obstructive sleep apnea. CPT: pharmacometrics & systems pharmacology (2024)
Alzahra Hamdan, Andrew C Hooker, Xiaomei Chen, Andreas Traschütz, Rebecca Schüle, null null, null null, Matthis Synofzik, Mats O Karlson
Item performance of the scale for the assessment and rating of ataxia in rare and ultra-rare genetic ataxias. CPT: pharmacometrics & systems pharmacology 13 (8) (2024)
Leticia Arrington, Mats O Karlson
Comparison of Two Methods for Determining Item Characteristic Functions and Latent Variable Time-Course for Pharmacometric Item Response Models. The AAPS journal 26 (1) (2024)
Xiaomei Chen, Henrik B Nyberg, Mark Donnelly, Liang Zhao, Lanyan Fang, Mats O Karlson, Andrew C Hooker
Development and comparison of model-integrated evidence approaches for bioequivalence studies with pharmacokinetic end points. CPT: pharmacometrics & systems pharmacology (2024)
Kinjal Sanghavi, Jakob Ribbing, James A Rogers, Mariam A Ahmed, Mats O Karlson, Nick H G Holford, Estelle Chasseloup, Malidi Ahamadi, Kenneth G Kowalski, Susan Cole, Essam Ghazaly, Janet R Wade, Chao Liu, Yaning Wang, Mirjam N Trame, Hao Zhu, Justin J Wilkins, null null
Covariate modeling in pharmacometrics: General points for consideration. CPT: pharmacometrics & systems pharmacology 13 (5) (2024)
Gustaf J Wellhagen, Mats O Karlson, Maria C Kjellsson, Dirk Garmann, Astrid Bröker, Yang Zhang, Mika Nokela, Gerrit Weimann, Ashraf Yassen
Item response theory analysis of daytime sleepiness as a symptom of obstructive sleep apnea. CPT: pharmacometrics & systems pharmacology 13 (5) (2024)
Joakim Nyberg, E Niclas Jonsson, Mats O Karlson, Jonas Häggström
Properties of the full random-effect modeling approach with missing covariate data. Statistics in medicine 43 (5) (2023)
Sreenath M Krishnan, Lena E Friberg, Francois Mercier, Rong Zhang, Benjamin Wu, Jin Yan Jin, Tien Hoang, Marcus Ballinger, René Bruno, Mats O Karlson
Multistate Pharmacometric Model to Define the Impact of Second-Line Immunotherapies on the Survival Outcome of the IMpower131 Study. Clinical pharmacology and therapeutics 113 (4) (2023)
Estelle Chasseloup, Mats O Karlson, null null
Comparison of Seven Non-Linear Mixed Effect Model-Based Approaches to Test for Treatment Effect. Pharmaceutics 15 (2) (2023)
Han Liu, Ana-Marija Milenković-Grišić, Sreenath M Krishnan, Siv Jonsson, Lena E Friberg, Pascal Girard, Karthik Venkatakrishnan, Yulia Vugmeyster, Akash Khandelwal, Mats O Karlson
A multistate modeling and simulation framework to learn dose-response of oncology drugs: Application to bintrafusp alfa in non-small cell lung cancer. CPT: pharmacometrics & systems pharmacology (2023)
Joakim Nyberg, E Niclas Jonsson, Mats O Karlson, Jonas Häggström
Properties of the full random-effect modeling approach with missing covariate data. Statistics in medicine 43 (5) (2023)
Sreenath M Krishnan, Lena E Friberg, Francois Mercier, Rong Zhang, Benjamin Wu, Jin Yan Jin, Tien Hoang, Marcus Ballinger, René Bruno, Mats O Karlson
Multistate Pharmacometric Model to Define the Impact of Second-Line Immunotherapies on the Survival Outcome of the IMpower131 Study. Clinical pharmacology and therapeutics 113 (4) (2023)
Eman I K Ibrahim, Mats O Karlson, Lena E Friberg
Assessment of Ibrutinib Scheduling on Leukocyte, Lymph Node Size and Blood Pressure Dynamics in Chronic Lymphocytic Leukemia through Pharmacokinetic-Pharmacodynamic Models. CPT: pharmacometrics & systems pharmacology (2023)
Joakim Nyberg, E Niclas Jonsson, Mats O Karlson, Jonas Häggström
Properties of the full random-effect modeling approach with missing covariate data. Statistics in medicine (2023)
Estelle Chasseloup, Mats O Karlson, null null
Comparison of Seven Non-Linear Mixed Effect Model-Based Approaches to Test for Treatment Effect. Pharmaceutics 15 (2) (2023)
Sreenath M Krishnan, Lena E Friberg, Francois Mercier, Rong Zhang, Benjamin Wu, Jin Yan Jin, Tien Hoang, Marcus Ballinger, René Bruno, Mats O Karlson
Multistate Pharmacometric Model to Define the Impact of Second-Line Immunotherapies on the Survival Outcome of the IMpower131 Study. Clinical pharmacology and therapeutics (2023)
Joakim Nyberg, E Niclas Jonsson, Mats O Karlson, Jonas Häggström
Properties of the full random-effect modeling approach with missing covariate data. Statistics in medicine 43 (5) (2023)
Sreenath M Krishnan, Lena E Friberg, Francois Mercier, Rong Zhang, Benjamin Wu, Jin Yan Jin, Tien Hoang, Marcus Ballinger, René Bruno, Mats O Karlson
Multistate pharmacometric model to define the impact of second-line immuno-therapies on the survival outcome of IMpower131 study. Clinical pharmacology and therapeutics (2023)
Laura H Bukkems, Siv Jonsson, Marjon H Cnossen, Mats O Karlson, Ron A A Mathôt, null null
Relationship between factor VIII levels and bleeding for rFVIII-SingleChain in severe hemophilia A: A repeated time-to-event analysis. CPT: pharmacometrics & systems pharmacology (2023)
Po-Wei Chen, Mats O Karlson, Sebastian Ueckert, Ari Pritchard-Bell, Cheng-Pang Hsu, Sandeep Dutta, Malidi Ahamadi
Evaluation of the Effect of Erenumab on Migraine-Specific Questionnaire in Patients with Chronic and Episodic Migraine. CPT: pharmacometrics & systems pharmacology (2023)
Joakim Nyberg, E Niclas Jonsson, Mats O Karlson, Jonas Häggström
Properties of the full random-effect modeling approach with missing covariate data. Statistics in medicine (2023)
Estelle Chasseloup, Mats O Karlson, null null
Comparison of Seven Non-Linear Mixed Effect Model-Based Approaches to Test for Treatment Effect. Pharmaceutics 15 (2) (2023)
Lénaïg Tanneau, Mats O Karlson, Susan L Rosenkranz, Yoninah S Cramer, Justin Shenje, Caryn M Upton, Joel Morganroth, Andreas H Diacon, Gary Maartens, Kelly E Dooley, Elin M Svenson
Assessing Prolongation of the Corrected QT Interval with Bedaquiline and Delamanid Coadministration to Predict the Cardiac Safety of Simplified Dosing Regimens. Clinical pharmacology and therapeutics 112 (4) (2022)
Carolina Llanos-Paez, Claire Ambery, Shuying Yang, Misba Beerahee, Elodie L Plan, Mats O Karlson
Improved Confidence in a Confirmatory Stage by Application of Item-Based Pharmacometrics Model: Illustration with a Phase III Active Comparator-Controlled Trial in COPD Patients. Pharmaceutical research 39 (8) (2022)
Robin J Svensson, Jakob Ribbing, Naoki Kotani, Michael Dolton, Shweta Vadhavkar, Dorothy Cheung, Tracy Staton, David F Choy, Wendy Putnam, Jin Jin, Nageshwar Budha, Mats O Karlson, Angelica Quartino, Rui Zhu
Population repeated time-to-event analysis of exacerbations in asthma patients: A novel approach for predicting asthma exacerbations based on biomarkers, spirometry, and diaries/questionnaires. CPT: pharmacometrics & systems pharmacology 10 (10) (2021)
Chao Chen, Siv Jonsson, Shuying Yang, Elodie L Plan, Mats O Karlson
Detecting placebo and drug effects on Parkinson's disease symptoms by longitudinal item-score models. CPT: pharmacometrics & systems pharmacology 10 (4) (2021)
Estelle Chasseloup, Gunnar Yngman, Mats O Karlson
Comparison of covariate selection methods with correlated covariates: prior information versus data information, or a mixture of both? Journal of pharmacokinetics and pharmacodynamics 47 (5) (2020)
Leticia Arrington, Sebastian Ueckert, Malidi Ahamadi, Sreeraj Macha, Mats O Karlson
Performance of longitudinal item response theory models in shortened or partial assessments. Journal of pharmacokinetics and pharmacodynamics 47 (5) (2020)
Eva Germovsek, Anna Hansson, Maria C Kjellsson, Juan Jose Perez Ruixo, Åke Westin, Paul A Soons, An Vermeulen, Mats O Karlson
Relating Nicotine Plasma Concentration to Momentary Craving Across Four Nicotine Replacement Therapy Formulations. Clinical pharmacology and therapeutics 107 (1) (2019)
Andreas Krause, Charlotte Kloft, Wilhelm Huisinga, Mats O Karlson, José Pinheiro, Robert R Bies, James Rogers, France Mentré, Bret J Musser, null null
Comment on Jaki et al., A proposal for a new PhD level curriculum on quantitative methods for drug development. Pharmaceutical Statistics 17 (5):593-606, Sep/Oct 2018, DOI: 10.1002/pst.1873. Pharmaceutical statistics 18 (3) (2019)
Ida Netterberg, Mats O Karlson, Elisabet I Nielsen, Angelica L Quartino, Henrik Lindman, Lena E Friberg
The risk of febrile neutropenia in breast cancer patients following adjuvant chemotherapy is predicted by the time course of interleukin-6 and C-reactive protein by modelling. British journal of clinical pharmacology 84 (3) (2018)
Ida Netterberg, Elisabet I Nielsen, Lena E Friberg, Mats O Karlson
Model-based prediction of myelosuppression and recovery based on frequent neutrophil monitoring. Cancer chemotherapy and pharmacology 80 (2) (2017)

Mats O Karlson.css-eqlu8i{font-size:small;padding-left:4px;} (Mats O Karlsson, Mats Karlsson)

Publication Activity (10 Years)

Top Topics

Top Venues

Mats O Karlson (Mats O Karlsson, Mats Karlsson)